Superoxide is a potential culprit of caspase-3 dependent endothelial cell death induced by lysophosphatidylcholine

Journal of Physiology and Pharmacology

Volumn 61, Issue 4, 2010, Pages 375-381

  Park, S ^a   Kim, J A ^a   Choi, S ^b   Suh, S H ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Apoptosis; Atherosclerosis; Caspase 3; Endothelial cells; Lysophosphatidylcholine; Nitric oxide; Superoxide

Indexed keywords

CASPASE 3; ENZYME ANTIBODY; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRATHIOMOLYBDATE AMMONIUM; XANTHINE; XANTHINE OXIDASE;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NICK END LABELING; PROTEIN CLEAVAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; WESTERN BLOTTING;

ATHEROSCLEROSIS; CASPASE 3; CELL DEATH; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; LYSOPHOSPHATIDYLCHOLINES; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 77957032598     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction. Testing and clinical relevance. Circulation 2007; 115: 1285-1295.
2. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111: 363-368.
3. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007; 14: 3209-3220.
4. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32.
5. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001; 33: 1673-1690.
6. Matsubara M, Hasegawa K. Benidipine, a dihydropyridinecalcium channel blocker, prevents lysophosphatidylcholineinduced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 2005; 178: 57-66.
7. Matsubara M, Yao K, Hasegawa K. Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release. Pharmacol Res 2006; 53: 35-43.
8. Takahashi M, Okazaki H, Ogata Y, Takeuchi K, Ikeda U, Shimada K. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 2002; 161: 387-394.
9. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4: 139-163.
10. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74: 139-162.
11. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54: 469-487.
12. Kurzelewski M, Czarnowska E, Beresewicz A. Superoxideand nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guineapig heart. J Physiol Pharmacol 2005; 56: 163-178.
13. Madamanchi NR, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost 2005; 3: 254-267.
14. Yokoyama M. Oxidant stress and atherosclerosis. Curr Opin Pharmacol 2004; 4: 110-115.
15. Guzik TJ, Sadowski J, Guzik B, et al. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 333-339.
16. Watanabe N, Zmijewski JW, Takabe W, et al. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 2006; 168: 1737-1748.
17. Kugiyama K, Sugiyama S, Ogata N, et al. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 1999; 143: 201-204.
18. Wink DA, Miranda KM, Espey MG, et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 2001; 3: 203-213.
19. Mohanakumar KP, Thomas B, Sharma SM, Muralikrishnan D, Chowdhury R, Chiueh CC. Nitric oxide: an antioxidant and neuroprotector. Ann NY Acad Sci 2002; 962: 389-401.
20. Takeshita S, Inoue N, Gao D, et al. Lysophosphatidylcholine enhances superoxide anions production via endothelial nadh/nadph oxidase. J Atheroscler Thromb 2000; 7: 238-246.
21. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase c activation. Arterioscler Thromb 1994; 14: 1007-1013.
22. Nishioka H, Horiuchi H, Arai H, Kita T. Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils. FEBS Lett 1998; 441: 63-66.
23. Choi S, Park S, Liang GH, Kim JA, Suh SH. Superoxide generated by lysophosphatidylcholine induces endothelial nitric oxide synthase downregulation in human endothelial cells. Cell Physiol Biochem 2010; 25: 233-240.
24. Jameel NM, Thirunavukkarasu C, Wu T, Watkins SC, Friedman SL, Gandhi CR. P38-mapk- and caspase-3- mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by retinoic acid. J Cell Physiol 2009; 218: 157-166.
25. Newaz MA, Yousefipour Z, Nawal N, Adeeb N. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gammatocotrienol. J Physiol Pharmacol 2003; 54: 319-327.
26. Safaya R, Chai H, Kougias P, et al. Effect of lysophosphatidylcholine on vasomotor functions of porcine coronary arteries. J Surg Res 2005; 126: 182-188.
27. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319-324.
28. Yang Z, Ming XF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006; 4: 53-65.
29. Channon KM, Guzik TJ. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 2002; 53: 515-524.
30. Croset M, Brossard N, Polette A, Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000; 345(Pt 1): 61-67.
31. 2+ system in hl-60 leukaemia cells. Biochem J 1998; 336: 491-500.
32. Okita M, Gaudette DC, Mills GB, Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysopc) in ovarian cancer patients. Int J Cancer 1997; 71: 31-34.
33. Gillett MP, Besterman EM. Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases. Atherosclerosis 1975; 22: 111-124.
34. Chen L, Liang B, Froese DE, et al. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res 1997; 38: 546-553.